206 related articles for article (PubMed ID: 20693473)
1. Placebo group needed for interpretation of combination trial.
El-Mallakh RS; Kaur G; Lippman S
Am J Psychiatry; 2010 Aug; 167(8):996; author reply 996-7. PubMed ID: 20693473
[No Abstract] [Full Text] [Related]
2. The value of data on suicidality by treatment arm.
Smith EG
Am J Psychiatry; 2010 Aug; 167(8):995; author reply 995-6. PubMed ID: 20693471
[No Abstract] [Full Text] [Related]
3. The search for improved antidepressant strategies: is bigger better?
Coryell W
Am J Psychiatry; 2011 Jul; 168(7):664-6. PubMed ID: 21724669
[No Abstract] [Full Text] [Related]
4. Placebo-controlled, antidepressant clinical trials cannot be shortened to less than 4 weeks' duration: a pooled analysis of randomized clinical trials employing a diagnostic odds ratio-based approach.
Tedeschini E; Fava M; Papakostas GI
J Clin Psychiatry; 2011 Jan; 72(1):98-113. PubMed ID: 21208576
[TBL] [Abstract][Full Text] [Related]
5. Innovation and placebos in research: a new design of clinical trial.
Holbrook A; Goldsmith C
Lancet; 2003 Dec; 362(9401):2036-7. PubMed ID: 14697799
[No Abstract] [Full Text] [Related]
6. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.
Hida E; Tango T
J Biopharm Stat; 2013; 23(4):774-89. PubMed ID: 23799810
[TBL] [Abstract][Full Text] [Related]
7. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
Iovieno N; Papakostas GI
J Clin Psychiatry; 2012 May; 73(5):676-83. PubMed ID: 22569112
[TBL] [Abstract][Full Text] [Related]
8. Are concerns about the ethics of placebos a stalking horse for other issues?
Healy D
Am J Bioeth; 2002; 2(2):17-9. PubMed ID: 12189063
[No Abstract] [Full Text] [Related]
9. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
[TBL] [Abstract][Full Text] [Related]
10. The enrichment window approach as a means of dealing with placebo response in antidepressant clinical trials.
Mallinckrodt CH; Prucka WR
Clin Pharmacol Ther; 2010 Nov; 88(5):592-4. PubMed ID: 20959845
[TBL] [Abstract][Full Text] [Related]
11. Relationship between probability of receiving placebo and probability of prematurely discontinuing treatment in double-blind, randomized clinical trials for MDD: a meta-analysis.
Tedeschini E; Fava M; Goodness TM; Papakostas GI
Eur Neuropsychopharmacol; 2010 Aug; 20(8):562-7. PubMed ID: 20219330
[TBL] [Abstract][Full Text] [Related]
12. The STAR*D Trial: It Is Time to Reexamine the Clinical Beliefs That Guide the Treatment of Major Depression.
Pigott HE
Can J Psychiatry; 2015 Jan; 60(1):9-13. PubMed ID: 25886544
[No Abstract] [Full Text] [Related]
13. The absence of a placebo group is a serious limitation of the STAR*D trial.
Gorman DA; Abi-Jaoude E
Can J Psychiatry; 2011 Feb; 56(2):126; author reply 126-7. PubMed ID: 21438419
[No Abstract] [Full Text] [Related]
14. A general approach for sample size calculation for the three-arm 'gold standard' non-inferiority design.
Stucke K; Kieser M
Stat Med; 2012 Dec; 31(28):3579-96. PubMed ID: 22764073
[TBL] [Abstract][Full Text] [Related]
15. S-adenosyl methionine (SAMe) augmentation in major depressive disorder.
Nelson JC
Am J Psychiatry; 2010 Aug; 167(8):889-91. PubMed ID: 20693465
[No Abstract] [Full Text] [Related]
16. A Novel Study Design to Systematically Explore the Impact of Trial Methodology on Psychopharmacological Treatment Outcome in Patients with Depression.
Severus E; Sauer C; Bauer M; Ostacher M; Anghelescu IG
Pharmacopsychiatry; 2019 Jul; 52(4):170-174. PubMed ID: 29975972
[TBL] [Abstract][Full Text] [Related]
17. Placebo effect in depression.
Carpenter WT
Am J Psychiatry; 2009 Aug; 166(8):935. PubMed ID: 19651755
[No Abstract] [Full Text] [Related]
18. Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials.
Seemüller F; Möller HJ; Obermeier M; Adli M; Bauer M; Kronmüller K; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Schennach-Wolff R; Henkel V; Riedel M
J Clin Psychiatry; 2010 Nov; 71(11):1425-33. PubMed ID: 20816028
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants for bipolar depression.
Ghaemi SN; Goodwin FK
Am J Psychiatry; 2005 Aug; 162(8):1545-6; author reply 1547-8. PubMed ID: 16055786
[No Abstract] [Full Text] [Related]
20. STAR*D: what have we learned?
Rush AJ
Am J Psychiatry; 2007 Feb; 164(2):201-4. PubMed ID: 17267779
[No Abstract] [Full Text] [Related]
[Next] [New Search]
